BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25557171)

  • 1. Targeting of TGF-β-activated protein kinase 1 inhibits chemokine (C-C motif) receptor 7 expression, tumor growth and metastasis in breast cancer.
    Huang HL; Chiang CH; Hung WC; Hou MF
    Oncotarget; 2015 Jan; 6(2):995-1007. PubMed ID: 25557171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubocapsanolide A inhibits transforming growth factor-beta-activating kinase 1 to suppress NF-kappaB-induced CCR7.
    Pan MR; Chang HC; Wu YC; Huang CC; Hung WC
    J Biol Chem; 2009 Jan; 284(5):2746-2754. PubMed ID: 19049961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade.
    Choo MK; Kawasaki N; Singhirunnusorn P; Koizumi K; Sato S; Akira S; Saiki I; Sakurai H
    Mol Cancer Ther; 2006 Dec; 5(12):2970-6. PubMed ID: 17172402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
    Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
    J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
    Su ML; Chang TM; Chiang CH; Chang HC; Hou MF; Li WS; Hung WC
    PLoS One; 2014; 9(6):e98823. PubMed ID: 24915301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression.
    Neil JR; Schiemann WP
    Cancer Res; 2008 Mar; 68(5):1462-70. PubMed ID: 18316610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive association of TGF-beta-activated kinase 1 with the IkappaB kinase complex in the nucleus and cytoplasm of human neutrophils and its impact on downstream processes.
    Ear T; Fortin CF; Simard FA; McDonald PP
    J Immunol; 2010 Apr; 184(7):3897-906. PubMed ID: 20200282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.
    Zhang L; Fu Z; Li X; Tang H; Luo J; Zhang D; Zhuang Y; Han Z; Yin M
    Chem Biol Drug Des; 2017 Sep; 90(3):450-455. PubMed ID: 28224764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
    Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
    ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-target MDM2/MDMX inhibitor increases the sensitization of doxorubicin and inhibits migration and invasion abilities of triple-negative breast cancer cells through activation of TAB1/TAK1/p38 MAPK pathway.
    Fan Y; Li M; Ma K; Hu Y; Jing J; Shi Y; Li E; Dong D
    Cancer Biol Ther; 2019; 20(5):617-632. PubMed ID: 30462562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis.
    Pang MF; Georgoudaki AM; Lambut L; Johansson J; Tabor V; Hagikura K; Jin Y; Jansson M; Alexander JS; Nelson CM; Jakobsson L; Betsholtz C; Sund M; Karlsson MC; Fuxe J
    Oncogene; 2016 Feb; 35(6):748-60. PubMed ID: 25961925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage.
    Zhang D; Yan H; Li H; Hao S; Zhuang Z; Liu M; Sun Q; Yang Y; Zhou M; Li K; Hang C
    J Biol Chem; 2015 Aug; 290(32):19900-9. PubMed ID: 26100626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC chemokine receptor 7 promotes triple-negative breast cancer growth and metastasis.
    Wu J; Li L; Liu J; Wang Y; Wang Z; Wang Y; Liu W; Zhou Z; Chen C; Liu R; Yang R
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):835-842. PubMed ID: 30032244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross interference with TNF-alpha-induced TAK1 activation via EGFR-mediated p38 phosphorylation of TAK1-binding protein 1.
    Shin MS; Shinghirunnusorn P; Sugishima Y; Nishimura M; Suzuki S; Koizumi K; Saiki I; Sakurai H
    Biochim Biophys Acta; 2009 Jul; 1793(7):1156-64. PubMed ID: 19393267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 and TRAF6-dependent activation of TAK1 in the absence of TAB2 and TAB3.
    Zhang J; Macartney T; Peggie M; Cohen P
    Biochem J; 2017 Jun; 474(13):2235-2248. PubMed ID: 28507161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated TAK1 augments tumor growth and metastatic capacities of ovarian cancer cells through activation of NF-κB signaling.
    Cai PC; Shi L; Liu VW; Tang HW; Liu IJ; Leung TH; Chan KK; Yam JW; Yao KM; Ngan HY; Chan DW
    Oncotarget; 2014 Sep; 5(17):7549-62. PubMed ID: 25277189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.
    Ataie-Kachoie P; Badar S; Morris DL; Pourgholami MH
    Mol Cancer Res; 2013 Oct; 11(10):1279-91. PubMed ID: 23858099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAB4 stimulates TAK1-TAB1 phosphorylation and binds polyubiquitin to direct signaling to NF-kappaB.
    Prickett TD; Ninomiya-Tsuji J; Broglie P; Muratore-Schroeder TL; Shabanowitz J; Hunt DF; Brautigan DL
    J Biol Chem; 2008 Jul; 283(28):19245-54. PubMed ID: 18456659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.
    Kim SJ; Shin JY; Lee KD; Bae YK; Sung KW; Nam SJ; Chun KH
    Breast Cancer Res; 2012 Jan; 14(1):R14. PubMed ID: 22251626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
    Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
    Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.